Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*Abram Recht, David G. Pfister, George W. Sledge et al.|Journal of Clinical Oncology|2001Cited by 819
Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trialKathleen N. Moore, Bradley J. Monk, Angeles Alvarez Secord et al.|The Lancet Oncology|2019Cited by 533
Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignanciesArno J. Mundt, John C. Roeske, Anthony E. Lujan et al.|International Journal of Radiation Oncology*Biology*Physics|2002Cited by 468
Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group studyGini F. Fleming, James V. Fiorica, Michael W. Sill et al.|Gynecologic Oncology|2009Cited by 297
An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: A gynecologic oncology group studyT. Grushko, Gini F. Fleming, Virginia L. Filiaci et al.|Gynecologic Oncology|2007Cited by 181